Study of RE.DOCTOR Vitals® Software Accuracy

Status unconfirmed

Conditions studied: Respiratory Disorder, Cardiovascular Diseases, Diabetes, Pre-Diabetes, Primary Care

In brief

The purpose of this observational trial is to advance digital health monitoring through the analysis of Photoplethysmography (PPG) waveforms collected via RE.DOCTOR Vitals software. The study aims to collect a diverse and extensive dataset of PPG waveforms, alongside traditional physiological measurements, for the purpose of enhancing existing algorithms and machine learning models used in health monitoring. The primary focus is on improving the accuracy and reliability of algorithms in interpreting PPG data to derive meaningful insights into physiological parameters. The main questions it aims to answer are: * How can extensive datasets of PPG waveforms be utilized to enhance existing algorithms and machine learning models? * How do correlations between PPG waveforms and key physiological parameters (such as glucose levels, blood pressure, heart rate, respiration rate) contribute to refining algorithms for more accurate and reliable health predictions? Participants will be asked to: * Continuously monitor their health using smartphone applications. * Allow the collection of PPG waveforms in diverse settings. * Engage in tasks related to monitor health parameters using medically approved devices

Key facts

Study ID: NCT06237322
Run by: RE.DOCTOR LLC
People needed: 1000
Starts: 2024-03-01
Expected to finish: 2025-03-01
Last updated by the study team: 2024-02-05

Who can join

Age: 13 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Age between 13-80 years.
Ownership of a smartphone compatible with the designated data collection application.
Willingness to use the smartphone application for continuous PPG data collection.
Ability to provide informed consent for participation in the study.
No known history of conditions or medications that significantly affect PPG waveforms (e.g., severe arrhythmias, use of beta-blockers).
Healthy individuals and individuals with diagnosed CVD diseases, individuals with diagnosed pre-diabetes, diabetes I, diabetes II

You may not qualify if…

Age outside the specified range of 13-80 years.
Lack of ownership of a compatible smartphone.
Inability or unwillingness to use the designated smartphone application for data collection.
Known history of severe arrhythmias or use of medications affecting cardiovascular function.
Any condition that, in the judgment of the investigator, may compromise the participant's ability to complete the study.

Where it is running

Re.Doctor — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.